Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masataka Kuwana

Showing results (21-30 of 483) with videos related to

Pageof 49
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|August 5, 2004
[Collagen diseases with pulmonary involvement]Masataka Kuwana
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|May 16, 2017
Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease SubsettingMasataka Kuwana
The Journal of Rheumatology|May 3, 2017
A To-Do List at Diagnosis of Systemic Sclerosis with Positive Anti-RNA Polymerase III AntibodiesMasataka Kuwana
Rinsho Shinkeigaku = Clinical Neurology|January 27, 2012
[Myositis-specific and associated autoantibodies]Masataka Kuwana
Nature Reviews. Rheumatology|July 22, 2016
Inflammatory myopathies: Choosing the right biomarkers to predict ILD in myositisTakahisa Gono, Masataka Kuwana
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosisMasataka Kuwana, Yuka Okazaki
Cornea|January 6, 2004
Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantationYoko Ogawa, Masataka Kuwana
Expert Review of Clinical Immunology|November 30, 2019
Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositisTakahisa Gono, Masataka Kuwana
Inflammation and Regeneration|June 16, 2021
Updates on genetics in systemic sclerosisYuko Ota, Masataka Kuwana
The Lancet. Rheumatology|April 3, 2025
Is type I interferon score a promising circulating biomarker for systemic sclerosis?Yuichiro Shirai, Masataka Kuwana
Pageof 49

Showing results (21-30 of 483) with videos related to

Sort By:
Pageof 49
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|August 5, 2004
[Collagen diseases with pulmonary involvement]Masataka Kuwana
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|May 16, 2017
Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease SubsettingMasataka Kuwana
The Journal of Rheumatology|May 3, 2017
A To-Do List at Diagnosis of Systemic Sclerosis with Positive Anti-RNA Polymerase III AntibodiesMasataka Kuwana
Rinsho Shinkeigaku = Clinical Neurology|January 27, 2012
[Myositis-specific and associated autoantibodies]Masataka Kuwana
Nature Reviews. Rheumatology|July 22, 2016
Inflammatory myopathies: Choosing the right biomarkers to predict ILD in myositisTakahisa Gono, Masataka Kuwana
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosisMasataka Kuwana, Yuka Okazaki
Cornea|January 6, 2004
Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantationYoko Ogawa, Masataka Kuwana
Expert Review of Clinical Immunology|November 30, 2019
Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositisTakahisa Gono, Masataka Kuwana
Inflammation and Regeneration|June 16, 2021
Updates on genetics in systemic sclerosisYuko Ota, Masataka Kuwana
The Lancet. Rheumatology|April 3, 2025
Is type I interferon score a promising circulating biomarker for systemic sclerosis?Yuichiro Shirai, Masataka Kuwana
Pageof 49